Clinical Trials

2,517 enrolled

Phase 4 Active not recruiting

Prostatic Neoplasms

NCT04108208 2026-04-13

A Study of Apalutamide in Chinese Participants With Non Metastatic Castration Resistant Prostate Cancer (NM-CRPC)

75 enrolled 9 charts

Prostatic Neoplasms

NCT03419234 2026-04-01

Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel

223 enrolled 14 charts

Phase 1/2 Active not recruiting

Prostatic Neoplasms

NCT03543189 2026-04-01

Combination of Nivolumab Immunotherapy With Radiation Therapy and Androgen Deprivation Therapy

44 enrolled

Prostatic Diseases, Prostatic Neoplasms

NCT04191096 2026-03-20

KEYNOTE-991

Phase EARLY_PHASE1 Active not recruiting

1,251 enrolled 15 charts

Parkinson Disease 4, Autosomal Dominant Lewy Body

NCT05477823 2026-03-20

Imaging and Genomic Biomarkers to Predict Response in Prostate Cancer

30 enrolled

Prostatic Neoplasms

NCT07477626 2026-03-17

RADVAN

374 enrolled

Prostatic Neoplasms

NCT05884398 2026-03-12

LIBERTAS

420 enrolled

Metastatic Castrate-sensitive Prostate Cancer

NCT04748042 2026-03-06

Focal Radiation With Pulsed Systemic Therapy of Abiraterone, Androgen Deprivation Therapy (ADT), Lynparza Towards Castration Sensitive Oligometastatic Prostate Cancer (FAALCON)

21 enrolled

Prostatic Neoplasms

NCT02296229 2026-02-25

Stereotactic Body Radiation Therapy in Treating Patients With Localized High-Risk Prostate Cancer

220 enrolled

Prostatic Neoplasms

NCT04076059 2026-02-06

China ARCHES

180 enrolled 24 charts

Metastatic Hormone Sensitive Prostate Cancer

NCT04126070 2026-01-22

Nivolumab + Docetaxel + ADT in mHSPC Patients With DDRD or Inflamed Tumors

60 enrolled

Hormone Sensitive Prostate Cancer

NCT03456843 2026-01-21

Therapeutic Effect of Cytoreductive Radical Prostatectomy in Men With Newly Diagnosed Metastatic Prostate Cancer

190 enrolled

Stage IV Prostate Adenocarcinoma AJCC v7

NCT04267887 2026-01-20

Advanced ChemoHormonal Therapy for Treatment Naive Metastatic Prostate Cancer

7 enrolled

Prostatic Neoplasms

NCT02454543 2026-01-12

g-RAMPP

452 enrolled

Neoplasm Metastasis, Prostatic Neoplasms

NCT05746806 2025-12-31

HypoFocal SRT

36 enrolled

Prostatic Neoplasms

NCT03541850 2025-11-06

Stereotactic Body Radiation Therapy in Treating Patients With Localized Prostate Cancer That Have Undergone Surgery

92 enrolled

PSA Level Greater Than 0.03

NCT05628363 2025-11-05

Adaptive Stereotactic Body Radiation Therapy to the Prostate and Pelvic Nodes With Simultaneous Integrated Boost to the MR-detected Nodule for Patients With High-risk and Unfavorable Intermediate-risk Prostate Cancer

28 enrolled

Prostatic Neoplasms

NCT05100472 2025-11-04

A Study of Shorter Course Hormone Therapy and Radiation for High-risk Prostate Cancer

50 enrolled

Prostatic Neoplasms

NCT04743934 2025-05-04

RAD 2003

44 enrolled

Prostate Adenocarcinoma

NCT04624828 2025-04-24

IOSCAR

40 enrolled

Phase 1/2 Active not recruiting

Oligorecurrent and Oligoprogressive Prostate Cancer Patients

NCT05067140 2025-03-17

A Study of ARV-766 Given by Mouth in Men With Metastatic Prostate Cancer

152 enrolled

Genital Neoplasms, Male, Prostatic Neoplasms, Urogenital Neoplasms

NCT05676203 2025-02-17

ARASAFE

250 enrolled

Prostatic Neoplasms

NCT02303327 2024-12-09

Comparative Study of Radiotherapy Treatments to Treat High Risk Prostate Cancer Patients

307 enrolled

Prostatic Neoplasms

NCT03569241 2024-12-09

STORM

196 enrolled

Neoplasm Metastasis, Prostatic Neoplasms

NCT01957436 2024-11-12

PEACE1

1,173 enrolled

Phase 2/3 Active not recruiting

Neoplasms, Prostatic Neoplasms

NCT00268476 2023-04-18

STAMPEDE

11,992 enrolled

Phase 1/2 Active not recruiting

Prostatic Neoplasms

NCT05003752 2023-03-07

Hypo-Combi

40 enrolled